Skip to content
Medical Health Aged Care

Momentous reform will improve access to quality health care

Australian College of Nursing 2 mins read

The introduction of laws to remove outdated ‘collaborative arrangements’, which take effect from tomorrow 1 November, will allow Nurse Practitioners and Endorsed Midwives to autonomously provide Medicare services and prescribe Pharmaceutical Benefits Schedule (PBS) medications.

 

This is a big win for nurses and midwives who, since 2010, have had a legal requirement to have collaborative arrangements with a medical practitioner for them to be able to provide these services.

 

It is also a big win for patients who will now have better, quicker, and more affordable access to important care and treatments.

 

ACN CEO, Adjunct Professor Kathryn Zeitz FACN, said this momentous reform will allow Endorsed Midwives and Nurse Practitioners to use their education and skills to work to their full scope of practice, practise autonomously, and deliver more care to patients.

 

“It will have a significant positive impact on health service delivery, especially for those who live in rural, regional, and remote communities, and other underserved communities,” Adjunct Professor Zeitz said.

 

“The removal of collaborative arrangements will provide nurses and midwives with much-deserved respect and acknowledgement of their clinical expertise.

 

“The requirement to have a collaborative arrangement has limited the ability and opportunities and career progression of many appropriately qualified Nurse Practitioners.

 

“We hope this landmark change will help attract more Registered Nurses to become Nurse Practitioners and more Midwives to become Endorsed.

 

“Primary health care Nurse Practitioners support diverse groups, including people in aged care, First Nations peoples, and people with disabilities.

 

“They are also often the most highly qualified – or the only – health professional in many rural and remote communities.

 

“Endorsed Midwives and Nurse Practitioners working in these settings have been establishing innovative health services.

 

“They will now be able to practise autonomously. Patients will benefit. Communities will benefit.

 

“ACN congratulates the Government – especially Health Minister Mark Butler and Assistant Health Minister Ged Kearney – for driving this welcome and much-needed reform,” Adjunct Professor Zeitz said.

 

For more information:

Kirsty Waterford 0403 295 934

Email: acn.media@acn.edu.au

 

Social media channels:            Facebook: https://www.facebook.com/acnursing
                                                      Twitter: https://twitter.com/acn_tweet
                                                      LinkedIn: http://www.linkedin.com/company/australian-college-of-nursing
                                                      Instagram: https://www.instagram.com/acn_nursing

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 17/02/2025
  • 15:07
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG Announces Keynote Speaker for 2025 Annual Scientific Meeting: A/Professor Carien Creutzberg

The Australia New ZealandGynaecological Oncology Group (ANZGOG) is pleased to welcome internationally renowned Radiation Oncologist Professor Carien Creutzberg as a keynote speaker at the…

  • Contains:
  • Medical Health Aged Care
  • 17/02/2025
  • 11:51
Monash University

Monash Expert: Landmark approval of weight loss drug for heart disease

For the first time in Australia, a weight loss drug has been approved to also treat cardiovascular disease in overweight and obese patients. The Therapeutic Goods Administration (TGA) has granted approval for semaglutide 2.4 mg (sold as Wegovy) to be used as a complementary therapy for reducing major adverse cardiovascular events such as cardiovascular death, non-fatal myocardial infarction (heart attack), or non-fatal stroke. The approval follows findings from the SELECT trial, an international study involving more than 17,000 participants across 41 countries, including Australia. Results published in late 2023 showed that Wegovy reduced cardiovascular events by 20 percent in people…

  • Medical Health Aged Care
  • 17/02/2025
  • 10:11
Smith & Nephew UK Ltd

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction and lateral ankle instability repair*After anchor insertionSmith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of a comprehensive foot & ankle repair portfolio in Australia and New Zealand (ANZ) with proprietary adjustable tensioning technology. The ULTRABRIDGE◊ Adjustable Achilles Reconstruction and ULTRABRACE◊ Adjustable Ankle Instability Techniques are changing the way foot & ankle surgeons perform these repairs by allowing them to refine and optimise suture tension after anchor insertion.The ability to adjust tension for specific patients allows the surgeon to give the precise amount of range-of-motion…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.